There's something wrong about this, but I'm not sure what it is yet.
So, wait a minute......Terri could be helped?
The TriStem Group has been set up by Mr.Ghazi Dhoot and Dr. Ilham Saleh Abuljadayel to further research and develop its retrodifferentiation technology which is used to create stem cells from mature adult cells. The retrodifferentiation technology is based on the results of 12 years of research and currently TriStem is the only company that owns, and is in the process of commercialising, this technology. The main advantage of TriStem's new process over existing methods of harvesting stem cells is that it provides large quantities of stem cells which are by definition DNA matched and, therefore, bypasses the political and ethical issues concerned with therapeutic cloning.
Thanks for the post; Ping.
Please ping your list. This is very interesting!
Don't forget this announcement from Australia, where scientists at Griffith University are finding that the stem cells from the receptors in the nasal mucosa are amenable to differentiation to other cell lines and self-replicating.
Here's the Abstract from the original article (costs $25 to access the actual article and I promised not to publish it when I bought it, but the abstract and the CNN article ought to be sufficient unless you need to argue with a scientist.).
Dev Dyn. 2005 Mar 21; [Epub ahead of print]
Multipotent stem cells from adult olfactory mucosa.
Murrell W, Feron F, Wetzig A, Cameron N, Splatt K, Bellette B, Bianco J, Perry
C, Lee G, Mackay-Sim A.
Eskitis Institute for Cell and Molecular Therapies, Griffith University,
Multipotent stem cells are thought to be responsible for the generation of new
neurons in the adult brain. Neurogenesis also occurs in an accessible part of
the nervous system, the olfactory mucosa. We show here that cells from human
olfactory mucosa generate neurospheres that are multipotent in vitro and when transplanted into the chicken embryo. Cloned neurosphere cells show this multipotency. Multipotency was evident without prior culture in vitro: cells dissociated from adult rat olfactory mucosa generate leukocytes when transplanted into bone marrow-irradiated hosts, and cells dissociated from adult mouse olfactory epithelium generated numerous cell types when transplanted into the chicken embryo. It is unlikely that these results can be attributed to hematopoietic precursor contamination or cell fusion. These results demonstrate the existence of a multipotent stem-like cell in the olfactory mucosa useful for autologous transplantation therapies and for cellular studies of disease.
Developmental Dynamics, 2005. (c) 2005 Wiley-Liss, Inc.
PMID: 15782416 [PubMed - as supplied by publisher]
BOSTON -- Despite a veto threat from the governor, the state Senate overwhelmingly approved a bill Wednesday to give scientists more freedom to conduct embryonic stem cell research in Massachusetts.
The 35-2 vote came after less than two hours of debate, on the same day Gov. Mitt Romney launched a statewide radio campaign to urge the bill's defeat.
The Republican governor has promised to veto the measure, which would allow scientists to create cloned embryos and extract their stem cells for research into the treatment and cure of diabetes, Parkinson's disease, spinal cord injuries and other conditions.